Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #556 on Correvio Pharma (CORV)
powerbattles
12/24/19 9:15 AM
#557 RE: 420man #556
Correvio intends to request a meeting with the FDA as soon as possible to discuss the design and specifics of a potential study to address the FDA's concerns and currently believes that enrollment of both US and ex-US subjects may be acceptable to the Agency based on preliminary feedback.